MORGAN STANLEY - TETRAPHASE PHARMACEUTICALS I ownership

TETRAPHASE PHARMACEUTICALS I's ticker is TTPHXXXX and the CUSIP is 88165N105. A total of 66 filers reported holding TETRAPHASE PHARMACEUTICALS I in Q2 2014. The put-call ratio across all filers is 0.51 and the average weighting 0.2%.

Quarter-by-quarter ownership
MORGAN STANLEY ownership history of TETRAPHASE PHARMACEUTICALS I
ValueSharesWeighting
Q2 2019$2,000
-88.9%
4,638
-64.9%
0.00%
Q1 2019$18,000
-91.4%
13,209
-92.9%
0.00%
Q4 2018$209,000
-72.2%
184,958
-32.3%
0.00%
Q3 2018$753,000
+49.1%
273,022
+92.8%
0.00%
Q2 2018$505,000
+34.0%
141,575
+15.2%
0.00%
Q1 2018$377,000
-47.6%
122,843
+7.7%
0.00%
Q4 2017$719,000
-34.0%
114,095
-28.4%
0.00%
Q3 2017$1,090,000
-61.9%
159,441
-60.3%
0.00%
-100.0%
Q2 2017$2,862,000
-51.0%
401,420
-36.8%
0.00%0.0%
Q1 2017$5,838,000
+384.1%
635,434
+112.1%
0.00%
Q4 2016$1,206,000
+509.1%
299,596
+479.2%
0.00%
Q3 2016$198,000
+90.4%
51,730
+113.1%
0.00%
Q2 2016$104,000
-59.5%
24,279
-56.4%
0.00%
Q1 2016$257,000
+40.4%
55,633
+204.4%
0.00%
Q4 2015$183,000
-31.7%
18,276
-49.0%
0.00%
Q3 2015$268,000
-84.8%
35,844
-3.3%
0.00%
-100.0%
Q2 2015$1,758,000
+301.4%
37,057
+210.4%
0.00%
Q1 2015$438,000
-86.9%
11,939
-85.8%
0.00%
-100.0%
Q4 2014$3,347,000
+1456.7%
84,317
+679.9%
0.00%
Q3 2014$215,000
+207.1%
10,811
+108.4%
0.00%
Q2 2014$70,000
-20.5%
5,188
-36.0%
0.00%
Q1 2014$88,000
-25.4%
8,112
-6.6%
0.00%
Q4 2013$118,000
-79.3%
8,688
-89.3%
0.00%
Q2 2013$570,00081,0940.00%
Other shareholders
TETRAPHASE PHARMACEUTICALS I shareholders Q2 2014
NameSharesValueWeighting ↓
HARVEY CAPITAL MANAGEMENT INC 354,300$7,068,0002.77%
Opaleye Management Inc. 169,700$3,385,515,0002.64%
Broadfin Capital, LLC 959,247$19,137,0002.01%
Novo Holdings A/S 900,000$17,955,0001.75%
Eventide Asset Management 300,900$6,003,0000.84%
EAM Investors, LLC 152,595$3,044,0000.62%
COLUMBIA PARTNERS L.L.C. INVESTMENT MANAGEMENT 497,858$9,932,0000.51%
Granite Point Capital Management, L.P. 40,000$798,0000.40%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 450,191$8,981,0000.33%
TFS CAPITAL LLC 133,070$2,655,0000.23%
View complete list of TETRAPHASE PHARMACEUTICALS I shareholders